The pathological process underlying Alzheimer’s disease in individuals under thirty

Braak, Heiko, Del Tredici, Kelly·2011·Acta Neuropathologica
DOI 10.1007/s00401-010-0789-4

Cited by (813)

Items 101–200 of 813

  1. Invited review: Prion‐like transmission and spreading of tau pathology
    Clavaguera, Florence, Hench, Jürgen, Goedert, Michel, Tolnay, Markus · 2015 · Neuropathology and Applied Neurobiology
  2. GSK3 and Alzheimer’s disease: facts and fiction…
    Anna Kremer · 2011 · Frontiers in Molecular Neuroscience
  3. A Deposition in Aging Is Associated with Increases in Brain Activation during Successful Memory Encoding
    Elizabeth C. Mormino, Michael G. Brandel, Cindee M. Madison, Shawn M. Marks, Suzanne L. Baker, William J. Jagust · 2011 · Cerebral Cortex
  4. Pathology of the Aging Brain in Domestic and Laboratory Animals, and Animal Models of Human Neurodegenerative Diseases
    Sameh A. Youssef, Maria Tresa Capucchio, Jaime Rofina, James Kenn CHAMBERS, Kazuyuki Uchida, Hiroyuki Nakayama, Elizabeth Head · 2016 · Veterinary Pathology
  5. Frontotemporal Dementia: Implications for Understanding Alzheimer Disease
    Michel Goedert, Bernardino Francesco Ghetti, M. G. Spillantini · 2011 · Cold Spring Harbor Perspectives in Medicine
  6. Neuromelanin, aging, and neuronal vulnerability in Parkinson's disease
    Miquel Vila · 2019 · Movement Disorders
  7. Prion-like Mechanisms in the Pathogenesis of Tauopathies and Synucleinopathies
    Michel Goedert, Ben Falcon, Florence Clavaguera, Markus Tolnay · 2014 · Current Neurology and Neuroscience Reports
  8. Ushering in the study and treatment of preclinical Alzheimer disease
    Jessica B. S. Langbaum, Adam Fleisher, Kewei Chen, Napatkamon Ayutyanont, Francisco Javier Lopera, Yakeel T. Quiroz, Richard J. Caselli, Pierre N. Tariot, Eric M. Reiman · 2013 · Nature Reviews Neurology
  9. Targeting norepinephrine in mild cognitive impairment and Alzheimer's disease
    Termpanit Chalermpalanupap, Becky L. Kinkead, William T. Hu, Markus P. Kummer, Thea Hammerschmidt, Michael Thomas Heneka, David Weinshenker, Allan I. Levey · 2013 · Alzheimer s Research & Therapy
  10. Hallmarks of Alzheimer disease are evolving relentlessly in Metropolitan Mexico City infants, children and young adults. APOE4 carriers have higher suicide risk and higher odds of reaching NFT stage V at ≤ 40 years of age
    Lilian Calderón‐Garcidueñas, Angélica González-Maciel, Rafael Reynoso-Robles, Ricardo Delgado‐Chávez, Partha S. Mukherjee, Randy Joseph Kulesza, Ricardo Torres‐Jardón, José Ávila-Ramírez, Rodolfo Villarreal-Ríos · 2018 · Environmental Research
  11. Cell-to-Cell Transmission of Tau and α-Synuclein
    Uemura, Norihito, Uemura, Maiko T., Luk, Kelvin C., Lee, Virginia M.-Y., Trojanowski, John Q. · 2020 · Trends in Molecular Medicine
  12. Dystrophic microglia in late‐onset Alzheimer's disease
    Streit, Wolfgang J., Khoshbouei, Habibeh, Bechmann, Ingo · 2020 · Glia
  13. Meta-Review of CSF Core Biomarkers in Alzheimer’s Disease: The State-of-the-Art after the New Revised Diagnostic Criteria
    Daniel Ferreira, Lilisbeth Perestelo‐Pérez, Eric Westman, Lars‐Olof Wahlund, Antonio Sarría‐Santamera, Pedro Serrano‐Aguilar · 2014 · Frontiers in Aging Neuroscience
  14. The age of onset and evolution of Braak tangle stage and Thal amyloid pathology of Alzheimer’s disease in individuals with Down syndrome
    Yvonne S. Davidson, Andrew Robinson, V. P. Prasher, David M. A. Mann · 2018 · Acta Neuropathologica Communications
  15. Chronic sleep deprivation altered the expression of circadian clock genes and aggravated Alzheimer's disease neuropathology
    Long Niu, Feng Zhang, Xiaojiao Xu, Yuting Yang, Song Li, Hui Liu, Weidong Le · 2021 · Brain Pathology
  16. Intraneuronal tau aggregation precedes diffuse plaque deposition, but amyloid-β changes occur before increases of tau in cerebrospinal fluid
    Heiko Braak, Henrik Zetterberg, Kelly Del Tredici, Kaj Blennow · 2013 · Acta Neuropathologica
  17. Contemplating Alzheimer’s Disease and the Contribution of White Matter Hyperintensities
    Adam M. Brickman · 2013 · Current Neurology and Neuroscience Reports
  18. Intercellular Spread of Protein Aggregates in Neurodegenerative Disease
    Davis, Albert A., Leyns, Cheryl E.G., Holtzman, David M. · 2018 · Annual Review of Cell and Developmental Biology
  19. Alzheimer's disease cerebrospinal fluid biomarker in cognitively normal subjects
    Toledo, Jon B., Zetterberg, Henrik, van Harten, Argonde C., Glodzik, Lidia, Martinez-Lage, Pablo, Bocchio-Chiavetto, Luisella, Rami, Lorena, Hansson, Oskar, Sperling, Reisa, Engelborghs, Sebastiaan et al. · 2015 · Brain
  20. Human P301L-Mutant Tau Expression in Mouse Entorhinal-Hippocampal Network Causes Tau Aggregation and Presynaptic Pathology but No Cognitive Deficits
    Julie A. Harris, Akihiko Koyama, Sumihiro Maeda, Kaitlyn Ho, Nino Devidze, Dena B. Dubal, Gui-Qiu Yu, Eliezer Masliah, Lennart Mucke · 2012 · PLoS ONE
  21. Locus Coeruleus Ablation Exacerbates Cognitive Deficits, Neuropathology, and Lethality in P301S Tau Transgenic Mice
    Chalermpalanupap, Termpanit, Schroeder, Jason P., Rorabaugh, Jacki M., Liles, L. Cameron, Lah, James J., Levey, Allan I., Weinshenker, David · 2018 · The Journal of Neuroscience
  22. Characterizing tau deposition in chronic traumatic encephalopathy (CTE): utility of the McKee CTE staging scheme
    Michael Louis Alosco, Jonathan D. Cherry, Bertrand R. Huber, Yorghos Tripodis, Zachary Baucom, Neil W. Kowall, Nicole A. Saltiel, Lee E. Goldstein, Douglas I. Katz, Brigid C. Dwyer et al. · 2020 · Acta Neuropathologica
  23. Therapeutic strategies for tau mediated neurodegeneration
    Yasumasa Yoshiyama, Virginia M.‐Y. Lee, John Q. Trojanowski · 2012 · Journal of Neurology Neurosurgery & Psychiatry
  24. Potential Pathways of Abnormal Tau and α-Synuclein Dissemination in Sporadic Alzheimer's and Parkinson's Diseases
    Heiko Braak, Kelly Del Tredici · 2016 · Cold Spring Harbor Perspectives in Biology
  25. Cardiovascular risk factors, cortisol, and amyloid‐β deposition in Alzheimer's Disease Neuroimaging Initiative
    Jon B. Toledo, Estefanía Toledo, Michael Walter Weiner, Clifford R. Jack, William Jagust, Virginia M.‐Y. Lee, Leslie M. J. Shaw, John Q. Trojanowski · 2012 · Alzheimer s & Dementia
  26. “Prion‐Like” Templated Misfolding in Tauopathies
    Florence Clavaguera, Isabelle Lavenir, Ben Falcon, Stephan Frank, Michel Goedert, Markus Tolnay · 2013 · Brain Pathology
  27. Hyperphosphorylation determines both the spread and the morphology of tau pathology
    Wen Hui Hu, Xinhua Zhang, Yunn Chyn Tung, Shu-Tao Xie, Fei Liu, Khalid Iqbal · 2016 · Alzheimer s & Dementia
  28. Interaction between pathogenic proteins in neurodegenerative disorders
    K. A. Jellinger · 2011 · Journal of Cellular and Molecular Medicine
  29. Aluminum’s Involvement in the Progression of Alzheimer’s Disease
    Judie R. Walton · 2013 · Journal of Alzheimer s Disease
  30. Imaging in-vivo tau pathology in Alzheimer’s disease with THK5317 PET in a multimodal paradigm
    Konstantinos Chiotis, Laure Saint‐Aubert, Irina Savitcheva, Vesna Jelić, Pia Andersen, My Jonasson, Jonas Eriksson, Mark Lubberink, Ove Almkvist, Anders E. Wall et al. · 2016 · European Journal of Nuclear Medicine and Molecular Imaging
  31. Early Alzheimer’s and Parkinson’s Disease Pathology in Urban Children: Friend versus Foe Responses—It Is Time to Face the Evidence
    Lilian Calderón‐Garcidueñas, Maricela Franco-Lira, Antonieta Mora-Tiscareño, Humberto Medina‐Cortina, Ricardo Torres‐Jardón, Michael Kavanaugh · 2013 · BioMed Research International
  32. White Matter Hyperintensities, Systemic Inflammation, Brain Growth, and Cognitive Functions in Children Exposed to Air Pollution
    Lilian Calderón‐Garcidueñas, Antonieta Mora-Tiscareño, Martin Andreas Styner, Gilberto Gómez-Garza, Hongtu Zhu B, Ricardo Torres‐Jardón, Esperanza Carlos, Edelmira Solorio, Humberto Medina‐Cortina, Michael Kavanaugh et al. · 2012 · Journal of Alzheimer s Disease
  33. Rates of β-amyloid accumulation are independent of hippocampal neurodegeneration
    Clifford R. Jack, Heather J. Wiste, David S. Knopman, Prashanthi Vemuri, Michelle M. Mielke, Stephen D. Weigand, Matthew L. Senjem, Jeffrey L. Gunter, Val J. Lowe, Brian E. Gregg et al. · 2014 · Neurology
  34. Stages of granulovacuolar degeneration: their relation to Alzheimer’s disease and chronic stress response
    Dietmar Rudolf Thal, Kelly Del Tredici, Albert Christian Ludolph, Jeroen J.M. Hoozemans, Annemieke J.M. Rozemüller, Heiko Braak, Uwe Knippschild · 2011 · Acta Neuropathologica
  35. Chronic Aluminum Intake Causes Alzheimer's Disease: Applying Sir Austin Bradford Hill's Causality Criteria
    Judie R. Walton · 2014 · Journal of Alzheimer s Disease
  36. Basal forebrain atrophy correlates with amyloid β burden in Alzheimer's disease
    Georg M. Kerbler, Jürgen Fripp, Christopher Cleon Rowe, Victor L. Villemagne, Olivier Salvado, Stephen Rose, Elizabeth Jane Coulson · 2014 · NeuroImage Clinical
  37. A single ultrasensitive assay for detection and discrimination of tau aggregates of Alzheimer and Pick diseases
    Michael A. Metrick, Natalia Ferreira, Eri Saijo, Allison Kraus, Kathy L. Newell, Gianluigi Zanusso, Michele Vendruscolo, Bernardino Francesco Ghetti, Byron W. Caughey · 2020 · Acta Neuropathologica Communications
  38. Genome instability in Alzheimer disease
    Hou, Yujun, Song, Hyundong, Croteau, Deborah L., Akbari, Mansour, Bohr, Vilhelm A. · 2017 · Mechanisms of Ageing and Development
  39. Aβ-induced acceleration of Alzheimer-related τ-pathology spreading and its association with prion protein
    Gomes, Luis Aragão, Hipp, Silvia Andrea, Rijal Upadhaya, Ajeet, Balakrishnan, Karthikeyan, Ospitalieri, Simona, Koper, Marta J., Largo-Barrientos, Pablo, Uytterhoeven, Valerie, Reichwald, Julia, Rabe, Sabine et al. · 2019 · Acta Neuropathologica
  40. The Locus Coeruleus in Aging and Alzheimer’s Disease: A Postmortem and Brain Imaging Review
    Rebecca Beardmore, Ruihua H. Hou, Angela Darekar, Clive Holmes, Delphine Boche · 2021 · Journal of Alzheimer s Disease
  41. Neurons in Vulnerable Regions of the Alzheimer’s Disease Brain Display Reduced ATM Signaling
    Xuting Shen, Jianmin Chen, Jiali Li, Julia Kofler, Karl Herrup · 2016 · eNeuro
  42. Pathogenesis of the Tauopathies
    Michel Goedert, Maria Grazia Spillantini · 2011 · Journal of Molecular Neuroscience
  43. Alzheimer disease
    Justin M. Nussbaum, Matthew E. Seward, George S. Bloom · 2013 · Prion
  44. Alzheimer disease
    Ana Laura Calderón‐Garcidueñas, Charles J. Duyckaerts · 2017 · Handbook of clinical neurology
  45. Potential Contribution of Exosomes to the Prion-Like Propagation of Lesions in Alzheimer’s Disease
    Vingtdeux, Valérie, Sergeant, Nicolas, Buée, Luc · 2012 · Frontiers in Physiology
  46. Progress and Developments in Tau Aggregation Inhibitors for Alzheimer Disease
    Bruno Bulic, Marcus Pickhardt, Eckhard Mandelkow� · 2013 · Journal of Medicinal Chemistry
  47. Neurotrophic factor small-molecule mimetics mediated neuroregeneration and synaptic repair: emerging therapeutic modality for Alzheimer’s disease
    Syed Faraz Kazim, Khalid Iqbal · 2016 · Molecular Neurodegeneration
  48. Synaptic tau: A pathological or physiological phenomenon?
    Miranda Robbins, Emma L. Clayton, Gabriele S. Kaminski Schierle · 2021 · Acta Neuropathologica Communications
  49. Altered sleep and EEG power in the P301S Tau transgenic mouse model
    Jerrah K. Holth, Thomas E. Mahan, Grace O. Robinson, Andréia Silva da Rocha, David M. Holtzman · 2017 · Annals of Clinical and Translational Neurology
  50. Turning on the Light Within: Subcortical Nuclei of the Isodentritic Core and their Role in Alzheimer’s Disease Pathogenesis
    Panos Theofilas, Sara Rose Dunlop, Helmut Heinsen, Lea T. Grinberg · 2015 · Journal of Alzheimer s Disease
  51. Selective Loss of Noradrenaline Exacerbates Early Cognitive Dysfunction and Synaptic Deficits in APP/PS1 Mice
    Thea Hammerschmidt, Markus P. Kummer, Dick Terwel, Ana Martinez, Ali Gorji, Hans‐Christian Pape, Karen S. Rommelfanger, Jason P. Schroeder, Monika Stoll, Joachim Ludwig Schultze et al. · 2012 · Biological Psychiatry
  52. The therapeutics of Alzheimer's disease: Where we stand and where we are heading
    Dennis J. Selkoe · 2013 · Annals of Neurology
  53. Identification of structural determinants on tau protein essential for its pathological function: novel therapeutic target for tau immunotherapy in Alzheimer’s disease
    Kontsekova, Eva, Zilka, Norbert, Kovacech, Branislav, Skrabana, Rostislav, Novak, Michal · 2014 · Alzheimer's Research & Therapy
  54. DNA methylation signature of human hippocampus in Alzheimer’s disease is linked to neurogenesis
    Miren Altuna, Amaya Urdánoz‐Casado, Javier Sánchez‐Ruiz de Gordoa, María Victoria Zelaya, Alberto Labarga, Julie M. J. Lepesant, Miren Roldán, Idoia Blanco‐Luquin, Álvaro Perdones-Montero, R Larumbe et al. · 2019 · Clinical Epigenetics
  55. Alzheimer's disease and alpha-synuclein pathology in the olfactory bulbs of infants, children, teens and adults ≤ 40 years in Metropolitan Mexico City. APOE4 carriers at higher risk of suicide accelerate their olfactory bulb pathology
    Calderón-Garcidueñas, Lilian, González-Maciel, Angélica, Reynoso-Robles, Rafael, Kulesza, Randy J., Mukherjee, Partha S., Torres-Jardón, Ricardo, Rönkkö, Topi, Doty, Richard L. · 2018 · Environmental Research
  56. Dura mater is a potential source of Aβ seeds
    Gábor Géza Kovács, Mirjam I. Lutz, Gerda Ricken, Thomas Ströbel, Romana Höftberger, Matthias Preusser, Günther Regelsberger, Selma Hönigschnabl, Angelika Reiner, Peter A. Fischer et al. · 2016 · Acta Neuropathologica
  57. Relationships between default-mode network connectivity, medial temporal lobe structure, and age-related memory deficits
    Andrew M. Ward, Elizabeth C. Mormino, Willem Huijbers, Aaron P. Schultz, Trey Hedden, Reisa Anne Sperling · 2014 · Neurobiology of Aging
  58. Longitudinal changes of tau PET imaging in relation to hypometabolism in prodromal and Alzheimer’s disease dementia
    Konstantinos Chiotis, Laure Saint‐Aubert, Elena Rodriguez‐Vieitez, Antoine Leuzy, Ove Almkvist, Irina Savitcheva, My Jonasson, Mark Lubberink, A. Wall, Gunnar Antoni et al. · 2017 · Molecular Psychiatry
  59. Longitudinal β-Amyloid Deposition and Hippocampal Volume in Preclinical Alzheimer Disease and Suspected Non–Alzheimer Disease Pathophysiology
    Gordon, Brian A., Blazey, Tyler, Su, Yi, Fagan, Anne M., Holtzman, David M., Morris, John C., Benzinger, Tammie L. S. · 2016 · JAMA Neurology
  60. Effects of ketone bodies in Alzheimer's disease in relation to neural hypometabolism, β‐amyloid toxicity, and astrocyte function
    Leif Hertz, Ye Chen, Helle S. Waagepetersen · 2015 · Journal of Neurochemistry
  61. A critical review of chronic traumatic encephalopathy
    Iverson, Grant L., Gardner, Andrew J., McCrory, Paul, Zafonte, Ross, Castellani, Rudy J. · 2015 · Neuroscience & Biobehavioral Reviews
  62. Amyloid, tau, pathogen infection and antimicrobial protection in Alzheimer’s disease –conformist, nonconformist, and realistic prospects for AD pathogenesis
    Li, Hongmei, Liu, Chia-Chen, Zheng, Hui, Huang, Timothy Y. · 2018 · Translational Neurodegeneration
  63. Alzheimer’s disease pathology: pathways between central norepinephrine activity, memory, and neuropsychiatric symptoms
    Heidi I.L. Jacobs, Joost M. Riphagen, Inez H.G.B. Ramakers, Frans R.J. Verhey · 2019 · Molecular Psychiatry
  64. Pathological Changes of Tau Related to Alzheimer’s Disease
    Dandan Chu, Fei Liu · 2018 · ACS Chemical Neuroscience
  65. Characteristics of Tau and Its Ligands in PET Imaging
    Ryuichi Harada, Nobuyuki Okamura, Shozo Furumoto, Tetsuro Tago, Kazuhiko Yanai, Hiroyuki Arai, Yukitsuka Kudo · 2016 · Biomolecules
  66. A phase II study repurposing atomoxetine for neuroprotection in mild cognitive impairment
    Allan I. Levey, Deqiang Qiu, Liping Zhao, William T. Hu, Duc Minh Duong, Lenora A. Higginbotham, Eric B. Dammer, Nicholas T. Seyfried, Thomas S. Wingo, Chadwick M. Hales et al. · 2021 · Brain
  67. Immunotherapy for Alzheimer's disease
    Thomas Wısnıewskı, Fernando Goñi · 2014 · Biochemical Pharmacology
  68. Structural MR Imaging in the Diagnosis of Alzheimer's Disease and Other Neurodegenerative Dementia: Current Imaging Approach and Future Perspectives
    Mina Park, Won‐Jin Moon · 2016 · Korean Journal of Radiology
  69. Tau passive immunization blocks seeding and spread of Alzheimer hyperphosphorylated Tau-induced pathology in 3 × Tg-AD mice
    Dai, Chun-ling, Hu, Wen, Tung, Yunn Chyn, Liu, Fei, Gong, Cheng-Xin, Iqbal, Khalid · 2018 · Alzheimer's Research & Therapy
  70. Spreading of amyloid, tau, and microvascular pathology in Alzheimer’s disease: Findings from neuropathological and neuroimaging studies.
    Thal, Dietmar Rudolf, Attems, Johannes, Ewers, Michael · 2014 · Journal of Alzheimer s Disease
  71. Are cases with tau pathology occurring in the absence of Aβ deposits part of the AD-related pathological process?
    Heiko Braak, Kelly Del Tredici · 2014 · Acta Neuropathologica
  72. Multimodal Brain Imaging Reveals Structural Differences in Alzheimer’s Disease Polygenic Risk Carriers: A Study in Healthy Young Adults
    Sonya F. Foley, Katherine E. Tansey, Xavier Caseras, Thomas Matthew Lancaster, Tobias Bracht, Greg D. Parker, Jérémy Hall, Julie H. Williams, David E.J. Linden · 2016 · Biological Psychiatry
  73. Axonal Degeneration in AD: The Contribution of Aβ and Tau
    Natalia Salvadores, Cristian Gerónimo‐Olvera, Felipe A. Court · 2020 · Frontiers in Aging Neuroscience
  74. Tau in neurodegenerative diseases: molecular mechanisms, biomarkers, and therapeutic strategies
    Xingyu Zhang, Jiangyu Wang, Zhentao Zhang, Keqiang Ye · 2024 · Translational Neurodegeneration
  75. Microglial activation occurs late during preclinical Alzheimer's disease
    Streit, Wolfgang J., Braak, Heiko, Del Tredici, Kelly, Leyh, Judith, Lier, Julia, Khoshbouei, Habibeh, Eisenlöffel, Christian, Müller, Wolf, Bechmann, Ingo · 2018 · Glia
  76. Quadruple abnormal protein aggregates in brainstem pathology and exogenous metal-rich magnetic nanoparticles (and engineered Ti-rich nanorods). The substantia nigrae is a very early target in young urbanites and the gastrointestinal tract a key brainstem portal
    Lilian Calderón‐Garcidueñas, Angélica González-Maciel, Rafael Reynoso-Robles, Jessica Hammond, Randy Joseph Kulesza, Ingolf Lachmann, Ricardo Torres‐Jardón, Partha S. Mukherjee, Barbara A. Maher · 2020 · Environmental Research
  77. Brainstem tau pathology in Alzheimer’s disease is characterized by increase of three repeat tau and independent of amyloid β
    Miho Uematsu, Ayako Nakamura, Momoko Ebashi, Katsuiku Hirokawa, Ryōsuke Takahashi, Toshiki Uchihara · 2018 · Acta Neuropathologica Communications
  78. Tau-driven degeneration of sleep- and wake-regulating neurons in Alzheimer’s disease
    Caroline Horton Lew, Cathrine Petersen, Thomas C. Neylan, Lea T. Grinberg · 2021 · Sleep Medicine Reviews
  79. Detection of Alzheimer Disease (AD)-Specific Tau Pathology in AD and NonAD Tauopathies by Immunohistochemistry With Novel Conformation-Selective Tau Antibodies
    Gibbons, Garrett S, Banks, Rachel A, Kim, Bumjin, Changolkar, Lakshmi, Riddle, Dawn M, Leight, Susan N, Irwin, David J, Trojanowski, John Q, Lee, Virginia M Y · 2018 · Journal of Neuropathology & Experimental Neurology
  80. SH-SY5Y-derived neurons: a human neuronal model system for investigating TAU sorting and neuronal subtype-specific TAU vulnerability
    Michael J. Bell, Hans Zempel · 2021 · Reviews in the Neurosciences
  81. Decreases in Short Term Memory, IQ, and Altered Brain Metabolic Ratios in Urban Apolipoprotein ε4 Children Exposed to Air Pollution
    Lilian Calderón‐Garcidueñas, Antonieta Mora-Tiscareño, Maricela Franco-Lira, Hongtu Zhu B, Zhaohua Lu, Edelmira Solorio, Ricardo Torres‐Jardón, Amedeo D’Angiulli · 2015 · Journal of Alzheimer s Disease
  82. Hyperphosphorylated tau in young and middle-aged subjects
    Adila El‐Obeid, Hilkka S. Soininen, Irina I. Alafuzoff · 2011 · Acta Neuropathologica
  83. In vivo mapping of brainstem nuclei functional connectivity disruption in Alzheimer’s disease
    Serra, Laura, D'Amelio, Marcello, Di Domenico, Carlotta, Dipasquale, Ottavia, Marra, Camillo, Mercuri, Nicola Biagio, Caltagirone, Carlo, Cercignani, Mara, Bozzali, Marco · 2018 · Neurobiology of Aging
  84. Intraneuronal Aβ accumulation and neurodegeneration: Lessons from transgenic models
    Oliver Wirths, Thomas A. Bayer · 2012 · Life Sciences
  85. Air pollution and detrimental effects on children’s brain. The need for a multidisciplinary approach to the issue complexity and challenges
    Lilian Calderón‐Garcidueñas, Ricardo Torres‐Jardón, Randy Joseph Kulesza, Subin Park, Amedeo Dâ€TMAngiulli · 2014 · Frontiers in Human Neuroscience
  86. Trimeric Tau Is Toxic to Human Neuronal Cells at Low Nanomolar Concentrations
    Tian, Huilai, Davidowitz, Eliot, Lopez, Patricia, Emadi, Sharareh, Moe, James, Sierks, Michael · 2013 · International Journal of Cell Biology
  87. Structural networks in Alzheimer's disease
    Andrew Reid, Alan Charles Evans · 2013 · European Neuropsychopharmacology
  88. Bidirectional links between Alzheimer's disease and Niemann–Pick type C disease
    Martina Malnar, Silva Katusic Hecimovic, Niklas Mattsson, Henrik Zetterberg · 2014 · Neurobiology of Disease
  89. Bacillus Calmette-Guérin (BCG) therapy lowers the incidence of Alzheimer’s disease in bladder cancer patients
    Ofer Nathan Gofrit, Benjamin Klein, Irun R. Cohen, Tamir Ben‐Hur, Charles L. Greenblatt, Hervé Bercovier · 2019 · PLoS ONE
  90. Ten Years of Tau-Targeted Immunotherapy: The Path Walked and the Roads Ahead
    Novak, Petr, Kontsekova, Eva, Zilka, Norbert, Novak, Michal · 2018 · Frontiers in Neuroscience
  91. The central role of tau in Alzheimer’s disease: From neurofibrillary tangle maturation to the induction of cell death
    Dietmar Rudolf Thal, Sandra O. Tomé · 2022 · Brain Research Bulletin
  92. Alzheimer disease starts in childhood in polluted Metropolitan Mexico City. A major health crisis in progress
    Lilian Calderón‐Garcidueñas, Ricardo Torres‐Jardón, Randy Joseph Kulesza, Yusra Mansour, Luis Oscar González‐González, Angélica González-Maciel, Rafael Reynoso-Robles, Partha S. Mukherjee · 2020 · Environmental Research
  93. Accelerated tau pathology with synaptic and neuronal loss in a novel triple transgenic mouse model of Alzheimer’s disease
    Saul, Anika, Sprenger, Frederik, Bayer, Thomas A., Wirths, Oliver · 2013 · Neurobiology of Aging
  94. Tauopathies: Deciphering Disease Mechanisms to Develop Effective Therapies
    M. Catarina Silva, Stephen J. Haggarty · 2020 · International Journal of Molecular Sciences
  95. Pharmacogenomics of Alzheimer’s Disease: Novel Therapeutic Strategies for Drug Development
    Ramón Cacabelos, Pablo Cacabelos, Clara Torrellas, Iván Tellado, Juan C. Carril · 2014 · Methods in molecular biology
  96. Recent Progress in Alzheimer’s Disease Research, Part 1: Pathology
    Francis T. Hane, Brenda Yasie Lee, Zoya Leonenko · 2017 · Journal of Alzheimer s Disease
  97. Tau prion-like propagation: state of the art and current challenges
    Dujardin, Simon, Hyman, Bradley T. · 2019 · Advances in Experimental Medicine and Biology
  98. Neuropathological assessment of the Alzheimer spectrum
    K. A. Jellinger · 2020 · Journal of Neural Transmission
  99. The Evolving Dialogue of Microglia and Neurons in Alzheimer’s Disease: Microglia as Necessary Transducers of Pathology
    Simon, E., Obst, J., Gomez-Nicola, D. · 2019 · Neuroscience
  100. Measurement of Tau Filament Fragmentation Provides Insights into Prion-like Spreading
    Franziska Kundel, Liu Hong, Benjamin Falcon, William A. McEwan, Thomas C. T. Michaels, Georg Meisl, Noemí Esteras, Andrey Y. Abramov, Tuomas P. J. Knowles, Michel Goedert et al. · 2018 · ACS Chemical Neuroscience